{"transactions":[{"id":2270553,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":127309,"kind":"person","name":"Demuth Tim","position":1,"cik":"0001875267","reported_name":"Demuth Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-16T20:19:05.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":6000,"price":1.71,"value":10260.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase price was 1.65 Euros per share which was converted into dollars using the noon buying rate of 1.00 Euro to $1.03745 based on information provided on May 13, 2022 via Xignite."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001583648-22-000030","document":"wf-form4_165274672969009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875267/000158364822000030/wf-form4_165274672969009.xml","form_type":"4"}},{"id":2375116,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":127309,"kind":"person","name":"Demuth Tim","position":1,"cik":"0001875267","reported_name":"Demuth Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-24T16:50:02.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":100000,"derivative":{"exercise_price":3.03,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-22-001876","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875267/000156218022001876/primarydocument.xml","form_type":"4"}},{"id":2618193,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":127309,"kind":"person","name":"Demuth Tim","position":1,"cik":"0001875267","reported_name":"Demuth Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-03T16:19:13.000Z","date":"2021-08-01","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on August 1, 2022 and vests as to an additional 6.25% of the option shares at the end of each successive calendar quarter thereafter beginning on December 31, 2022."}],"balance_after":360000,"derivative":{"exercise_price":3.48,"expiration_date":"2031-08-01","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001562180-21-005129","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875267/000156218021005129/primarydocument.xml","form_type":"4"}}]}